This study will evaluate the efficacy and safety of high-intensity rosuvastatin and moderate-intensity rosuvastatin/ezetimibe in ASCVD
Moderate-intensity statin therapy Rosuvastatin 5-10 mg Rosuvastatin Moderate Intensity Medications List Moderate-intensity statin therapy Simvastatin mg Simvastatin Moderate Intensity Medications List Moderate-intensity statin therapy Ezetimibe-simvastatin mg Ezetimibe Simvastatin Moderate Intensity Medications List Moderate
These findings suggest that the combination therapy of low-intensity rosuvastatin and ezetimibe is an useful alternative to moderate-intensity rosuvastatin monotherapy for cholesterol management
rosuvastatin, and simvastatin. Statin therapy is divided into 3 categories: high-intensity, moderate-intensity, and low-intensity. Statin efficacy is shown
by IH Yang 2024The combination of low intensity rosuvastatin and ezetimibe showed greater decrement of serum LDL-C level when compared with moderate intensity rosuvastatin.
In terms of rosuvastatin, the high-intensity rosuvastatin group showed a significantly higher cumulative incidence of NODM than moderate-intensity rosuvastatin group (8.3% vs. 5.8%, P = 0.004
moderate intensity pitavastatin in comparison to those of moderate intensity atorvastatin and rosuvastatin in AMI patients [14]. However
Background: To investigate the efficacy and safety of moderate-intensity rosuvastatin/ezetimibe combination compared to highintensity rosuvastatin in high
rosuvastatin group. This observation raised questions and stimulated In general, benefits of both moderate-intensity and high-intensity
Grin!